A previously described mouse peritonitis model was used to study derivatives of Enterococcus faecalis strain OG1RF. The addition of sterile rat fecal extracts (SRFE) lowered the LD 50 of OG1RF 110-fold. Hemolysin production caused a 35-fold lower LD 50 and a much shorter survival, similar to previous results using a peritonitis model without SRFE. A purine (but not a pyrimidine) auxotroph was considerably less lethal than wild type; gelatinase mutants were also attenuated. A suicide vector was generated with an enterococcal selectable marker in order to disrupt a gene encoding an E. faecalis antigen; the resulting mutant was not attenuated despite a slower growth rate. In conclusion, this model allows attenuated mutants to be detected, corroborates prior reports that hemolysin is a virulence factor, and suggests a role for gelatinase in virulence of E. faecalis in mice; the attenuated purine auxotroph may provide a system for developing vectors for in vivo expression systems.
Enterococci are important causes of human infections, among them endocarditis, urinary tract infections in hospitalized patients and in persons with urinary tract abnormalities, and infections related to breaches in the integrity of the gastrointestinal tract [1] . Although enterococcal endocarditis has long been recognized as a therapeutic challenge, especially when compared with endocarditis caused by streptococci, the emergence in the past decade of multiantibiotic-resistant enterococcal "super bugs" has converted some enterococci from being difficult to treat to being impossible to treat medically. The most clinically relevant enterococcal antibiotic resistances include high-level resistance to all aminoglycosides, which prevent the desired synergy usually needed to achieve cures in enterococcal endocarditis, and resistance to vancomycin, especially when it emerges in a strain highly resistant to ampicillin.
Because of the increasingly difficult therapeutic problems posed by enterococci, we recently initiated a series of studies into possible mechanisms of enterococcal virulence with the long-term goal of understanding how these problematic organisms cause infections. As part of this work, we identified a number of in vivo expressed enterococcal antigens [2] and began to generate alterations in these and other properties.
Because we planned to study the contribution of different genes to enterococcal virulence, we considered the merits of different animal models of infection. Models applied to enterococci have included models for endocarditis, pyelonephritis, endophthalmitis, and translocation [3] [4] [5] [6] . Peritonitis and intraabdominal abscess models, the former often with the addition of hog mucin, have been widely used to evaluate antimicrobial efficacy [7, 8] , the effect of hemolysin [9] , and to show synergism between enterococci and other organisms [3, 6] .
Because enterococci cause peritonitis and are a relatively common cause of infectious complications following gastrointestinal surgery and trauma, we decided to explore the utility of a peritonitis model that adds sterile rat fecal extracts (SRFE) to the inoculum [8] . Ike et al. [9] previously used a peritonitis model without SRFE to evaluate the contribution of hemolysin to mortality in mice; however, the SRFE modification described by Chenoweth et al. [8] seemed particularly relevant for intraabdominal-related enterococcal infections because it provides a sterile version of the debris that would be inoculated into the peritoneal cavity after spillage of intestinal contents. In the present study, we evaluated the effect on infection of adding SRFE and the capability of the model to show differences between Enterococcus faecalis derivatives before and after the introduction or disruption of certain genes. (table 1) , media, and antibiotics. E. faecalis OG1RF is a well-studied plasmid-free, gelatinase-producing strain [10] with spontaneous mutations for resistance to rifampin (Rif r ) and fusidic acid (Fus r ) [11] . OG1X is a gelatinase-defective mutant originally derived by mutagenesis with nitrosoguanidine of OG1-10, a streptomycin-resistant derivative of OG1 [11, 12] . TX5063a and TX5078 are purine and pyrimidine auxotrophs, respectively, previously generated using targeted insertion of the defective transposon mini-gd-200 (mgd) into OG1RF [13] ; these derivatives are highly resistant to kanamycin due to the presence of an enterococcal kanamycin-resistance gene (aph(3 )-IIIa) in mgd [14] . pAM714 is the hemolysin-encoding plasmid pAD1 with an insertion of Tn917 and encodes erythromycin resistance [9] (provided by D. Clewell, University of Michigan) in the OG1X background. This plasmid was transferred into OG1RF and the OG1RF-derived mutant, TX5128 (described below), by electroporation.
Materials and Methods

Bacterial strains
Routine media for growth of enterococci were brain-heart infusion (BHI) broth and agar (Difco Laboratories, Detroit) supplemented, as appropriate, with rifampin (100 mg/mL), fusidic acid (25 mg/mL), erythromycin (25 mg/mL), or kanamycin (2000 mg/mL). Gelatinase and hemolysin production were assayed as previously described [15] .
Generation of a gelatinase mutant. Cosmids in Escherichia coli containing the gelatinase gene (gelE) of OG1RF were identified by hybridizing colony lysates of a previously generated OG1RF genomic library [2] to an intragenic gelE probe. The probe was generated by polymerase chain reaction (PCR) using primers based on the published sequence of gelE (forward primer, gelEF1: 5 -TGGTATTGAGTTATGAGGG-3 ; reverse primer, gelER2: 5 -GATTCACTTGGTTGGTTTACC-3 ) [12] . To identify cosmids that contained the entire region between these primers, DNA from hybridizing clones was subjected to PCR using the primers. One PCR-positive clone was then mutagenized with mgd as previously described [13] . Since expression of gelatinase cannot be detected in E. coli [12] , cosmid DNA from a pool of mgd insertion mutants was prepared by equilibrium centrifugation in a CsCl-ethidium bromide gradient and used for electroporation [13] of OG1RF. Transformants were selected on BHI agar with 2000 mg/mL kanamycin and scored for gelatinase production as described [15] . The expected location of mgd in a gelatinase-defective mutant (designated TX5128) was demonstrated by hybridization of Southern blot filters containing restriction endonuclease-digested DNA from the mutant strain to the gel probe as described [13] . To further confirm the location of mgd within gelE, PCR using the gelE forward and/or reverse primers plus one primer for mgd [13] was also done.
Generation of an alteration in an in vivo expressed antigen. In our study of in vivo expressed antigens [2] , we identified an antigenencoding gene with homology to an Enterococcus faecium gene that encodes a protein, P54, of unknown function; this protein was originally identified because of cross-reactivity with an antibody to an ATPase [16] . It is predicted to be a surface protein, but database searches revealed no significant homologies. Because of our interest in evaluating surface proteins and antigens for possible roles in virulence, we generated a mutation in this gene in OG1RF. For this purpose, we constructed the vector pTEX4577 by digesting pBluescript SK(-) (Stratagene, La Jolla, CA) with ScaI, followed by blunt-ending with Klenow (Boehringer Mannheim, Indianapolis), then ligation to the kanamycin resistance gene of mgd. This resistance gene was generated by BamHI digestion of pMGD4 [14] , followed by blunt-ending this fragment with Klenow. pTEX4577 should serve as a suicide vector in E. faecalis. An ∼580-bp fragment of an immunoreactive subclone [2] of the P54 fs (fs for E. faecalis) gene (consisting of an ∼480-bp intragenic fragment of this gene together with ∼100 bp of vector sequence) was recloned into pTEX4577 using the SacI and KpnI sites (resulting in pTEX4578) and transformed into OG1RF by electroporation [13] ; recombinants were selected on BHI agar containing kanamycin (2000 mg/mL).
Mouse peritonitis model. BHI broth (300 mL) was inoculated with test bacteria and incubated overnight at 37ЊC with shaking at ∼150 rpm. The resulting cells were pelleted at 9000 rpm for 10 min at 10ЊC, resuspended in ∼50 mL of chilled 0.85% saline solution, and pelleted again as described. The washed pellets were resuspended in 20 mL of ice-cold 0.85% saline to obtain a stock of cfu/mL. Further dilutions (2-to 10-fold) were pre-10 ∼ 5 ϫ 10 pared in chilled saline. SRFE was prepared as described in [17] without barium, and each inoculum was diluted 1:10 in 50% SRFE to yield the desired final inocula. The actual number of colonyforming units was determined from the saline dilutions by further diluting and plating aliquots onto BHI agar plates.
We used female outbred ICR mice (Harlan Sprague-Dawley, Houston), aged 4-6 weeks, with a mean weight of 25 g. Groups of 6-10 mice were injected intraperitoneally with a 25-gauge needle with 1 mL of the premixed bacteria in 50% SRFE preparation [8] or in saline. Control mice were injected intraperitoneally with 1 mL of 50% SRFE only. Mice were housed 5 per cage and received food and water ad libitum throughout the duration of the experiment. Observations were made at least every 12 h over 1 week. Organisms were recovered from the kidneys or spleens of dead mice under aseptic conditions, and the presence of the inoculated organisms was confirmed. The LD 50 was determined by the method of Reed and Muench [18] using 2-fold dilutions of the inoculum. Survival estimates were computed by the Kaplan-Meier method and compared by log rank using StatView software (Abacus Concepts, Berkeley, CA). All organisms were tested more than once.
Results and Discussion
Effects of SRFE and hemolysin in the peritonitis model. We first evaluated the effect of adding SRFE to the inoculum on the ability of OG1RF to produce disease in mice. The LD 50 for OG1RF in the SRFE model ranged from 1.4 to cfu 4 ϫ 10 latter observation is consistent with the results of Ike et al. [9] , who used a peritonitis model that did not include SRFE and found that no mice died within 7 days after injection of cfu of OG1RF. Although all mice in the Ike study died 9 3 ϫ 10 within 18-72 h when given 10 10 cells, the necessity of such a high inoculum could make it very problematic to show attenuation.
After introduction of the hemolysin-encoding plasmid pAM714 (an erythromycin resistance version of wild type plasmid pAD1) into OG1RF, the LD 50 in the SRFE model was cfu, ∼35-fold lower than that of OG1RF. Most mice 6 8.7 ϫ 10 died within 5-8 h. Ike et al. [9] reported an LD 50 of 8 2.6 ϫ 10 cfu for this strain in the absence of SRFE, that is, 1-2 log 10 lower than the LD 50 for OG1RF alone, and all mice died within 4-5 h. That the increased lethality of OG1RF(pAM714) is likely due to hemolysin production was previously suggested by the demonstration of increased virulence of another Tn917 insertion mutant of pAD1 that was hyperhemolytic and the much decreased virulence of a Tn917 insertion mutant of pAD1 that was nonhemolytic. Our data from the modified model corroborate the findings of Ike et al. with respect to the contribution of hemolysin to total mortality and time to death in mice and also show that disease is produced by a lower inoculum in the presence of SRFE. Hemolysin can also increase the severity of endophthalmitis [19] and, when present with aggregation substance, increase mortality in an endocarditis model [20] . While survey studies have shown variability in the frequency of hemolysin among disease-associated isolates, particularly if clonality was not addressed, such data do not consider severity of disease once such an organism enters body tissues or blood.
Effect of inactivation of the gelatinase gene. Another property of E. faecalis that has been considered a possible virulence factor is gelatinase, a metalloproteinase. We previously found that gelatinase was produced by 54% of endocarditis isolates, 58% of nosocomial clinical isolates, 62% of nosocomial fecal isolates, and 27% of fecal isolates from healthy community volunteers ( for the latter group vs. each of the other 3).
Although results using different strains in an endocarditis model suggested that gelatinase might worsen the disease [21] , to our knowledge no studies have been published that have evaluated an effect of gelatinase on virulence of isogenic strains. By using OG1X, a gelatinase defective mutant of OG1RF [12] , we found it had a slight but consistently higher LD 50 of cfu (vs. for OG1RF) and was less rapidly 8 8 7.8 ϫ 10 4.8 ϫ 10 fatal than OG1RF. As shown in figure 1 , inocula of OG1X equal to or greater than inocula of OG1RF resulted in a prolonged survival by Kaplan-Meier analysis ( by log P ϭ .0007 rank for survival after inoculation of cfu of OG1RF 8 8 ϫ 10 vs.
cfu of OG1X, and by log rank for sur- 9 3.3 ϫ 10 P ϭ .0009 vival after cfu of OG1RF vs. cfu of OG1X). 9 9 2 ϫ 10 3.3 ϫ 10 Because OG1X was generated by nitrosoguanidine and may have other mutations and because this derivative produces some residual gelatinase after prolonged incubation [12] , we sought to evaluate the effect of introducing the gelatinase-encoding plasmid, pAM-S6 [12] , into OG1X. Although Gel ϩ colonies were recovered, the plasmid was unstable as was a related plasmid consisting of the lower copy number vector, pWM401 [22] . These constructs would have provided the gelatinase gene in multicopy, whereas the wild type OG1 has a single chromosomal copy. Therefore, to verify the effect of gelatinase, we next mutagenized a gelE-containing E. coli cosmid with mgd. After introducing a pool of mutant cosmids back into OG1RF, 40 kanamycin-resistant electrotransformants were spotted onto gelatin agar. One, designated TX5128, produced no detectable gelatinase, even after incubation for 72 h. The expected insertion by a double-crossover event was confirmed by restriction digestion and hybridization (data not shown). OG1X, in con- trast, produced a small halo after 48 h of incubation, indicating gelatinase activity. In the SRFE peritonitis model, the mgdgenerated gelatinase mutant TX5128 generated only a slightly higher LD 50 than did OG1RF ( cfu vs. 4.8) but pro- 8 6.8 ϫ 10 duced a significantly delayed time to death compared with OG1RF ( figure 1; by log rank for cfu), al-8 P ϭ .0007 8 ϫ 10 though there was somewhat less of a delay with TX5128 than with OG1X. Thus, this model shows differences between OG1RF and mutants of lesser virulence and also indicates that gelatinase, or possibly some function encoded by a gene downstream of gel, contributes to virulence. Confirming a role for gelatinase as a virulence factor in mice would require additional studies, such as introduction of the gelatinase gene as a single copy or demonstration that no other gene is encoded on the same transcript downstream of gelE. The greater attenuation of OG1X versus OG1RFgelE::mgd could be due to the presence of an independent mutation resulting from nitrosoguanidine mutagenesis or some other factor, such as an alteration in a regulator or changes in export.
We also assessed the effect of gelatinase production on the increase in virulence associated with the presence of hemolysin (figure 2). The production of gelatinase in E. faecalis interfered with the production of a hemolytic zone on blood agar plates [23] , raising the possibility of a negative interaction between these proteins. OG1RF, OG1X, and TX5128, each containing pAM714, generated about the same LD 50 (7.4-) ; the nongelatinase-producing hemolytic de- 6 8.8 ϫ 10 rivatives yielded a modest though statistically significant longer survival, by log rank for cfu 7 P ϭ .009 2.4 ϫ 10 OG1RF(pAM714) versus of OG1X(pAM714) and 7 2.8 ϫ 10 for OG1RF(pAM714) versus of 7 7 P ϭ .026 2.4 ϫ 10 3.4 ϫ 10 TX5128(pAM714). Thus, there was no evidence for in vivo interference or attenuation of hemolysin by gelatinase.
Effect of inactivation of pyrC and purL. Auxotrophic mutants have long been of interest in studies of pathogenesis, partly because they may be attenuated and thus of potential use as possible vaccine candidates [24] [25] [26] . In addition, the in vivo expression technology (IVET) described by Mahan et al. [27] used a purine auxotroph to develop a technology for detecting in vivo expressed genes. The auxotroph used in those studies (purA) was initially shown to be attenuated in an animal model. To explore whether development of a similar technology might be feasible in E. faecalis, two auxotrophs of OG1RF (pyrC::mgd and purL::mgd) previously generated by targeted insertion mutagenesis [13] were evaluated in the SRFE model. In initial experiments, the pyrC mutant did not appear less virulent. Since pyr mutations in other organisms show little or no attenuation [25, 26] , perhaps due to lower pyrimidine needs or higher amounts available from the host [25] , this mutant was not studied further. With the purL mutant, although the inocula used did not permit calculation of a precise LD 50 , the lowest inoculum of OG1RF ( cfu) produced ∼33% 8 2.7 ϫ 10 mortality (2 of 6 animals), while the highest inoculum of the OG1RFpurL::mgd (10 9 cfu) produced the same (33%) mortality. OG1RFpurL::mgd also showed a delay in its lethal effect ( for cfu of OG1RF vs. for purL 8 8 P ϭ .0004 6.4 ϫ 10 8.5 ϫ 10 mutant, log rank; for 10 9 OG1RF vs. 10 9 of purL P ϭ .0009 mutant). The reason for the attenuation of the pur mutant but not the pyr mutant is not known. Each grew equally well in a rich medium, but there are high levels of purine catabolic enzymes (e.g., adenosine deaminase) in some gut tissues [28] ; this might deplete purines, leading to poorer growth in vivo by a purine auxotroph. The demonstration of attenuation of this mutant provides a possible system for detecting in vivo expressed genes.
Evaluation of OG1RF with a mutation in the P54-like gene. After electroporating OG1RF with pTEX4578, kanamycinresistant colonies were subjected to restriction endonuclease digestion and hybridization to the ∼580-bp cloned P54 fs fragment. The expected gene disruption in OG1RF by a single crossover event into the P54 fs gene was confirmed (data not shown), illustrating the usefulness of this vector as a suicide vector. Colonies of TX5123, the mutant of OG1RF resulting from interruption of the gene encoding the P54 homolog, were smaller than those of OG1RF on BHI. In BHI broth cultures, TX5123 displayed a slower growth rate by both optical density and colony-forming unit determination compared with OG1RF (data not shown). In the peritonitis model, the LD 50 of TX5123 was about the same as for OG1RF, and there was no discernible difference in time to death at equivalent inocula of 1.0-cfu. Thus, despite the effect of this mutation on in vitro growth, there was no evidence in this model of an effect on virulence. In summary, these data show that inclusion of SRFE in a mouse peritonitis model lowers the LD 50 for E. faecalis OG1RF; this may be useful when evaluating an organism of relatively low virulence potential that otherwise may have to be administered at very high inocula or with less physiologic substances, such as hog mucin. This model allowed demonstration of attenuation of a purine, auxotroph, which could be used for designing an IVET-like system based on restoration of prototrophy and virulence in vivo. An evaluation of the effect of hemolysin production showed the same general effect as previously shown in a model without SRFE, except that the prior LD 50 was considerably lower with SRFE. Our results strongly suggest that gelatinase, which is commonly produced by nosocomial fecal and clinical enterococcal isolates, is a virulence factor for enterococci, at least for peritonitis in mice.
